Red light emission method and device capable of reducing blood sugar

Abstract

The invention provides a red light emission method and device capable of reducing blood sugar, and the method comprises the steps: obtaining historical blood sugar data, and extracting blood sugar abnormal data and blood sugar routine data from the historical blood sugar data; determining blood glucose variation corresponding to each emission wavelength based on each emission wavelength and blood glucose routine data; selecting one emission wavelength as a selected emission wavelength, determining a plurality of abnormal blood glucose margins through the selected emission wavelength, determining the abnormal reaction entropy of blood glucose according to the abnormal blood glucose margins and the blood glucose variation corresponding to the selected emission wavelength, and continuously determining the residual abnormal reaction entropy; acquiring light intensity reflection data, and determining an emission wavelength compensation amount according to the light intensity reflection data; and determining the wavelength adjustment cost through all the abnormal reaction entropies and the emission wavelength compensation amount, and carrying out wavelength regulation and control according to all the wavelength adjustment costs. By adopting the scheme of the invention, the wavelength of the red light emitting device can be dynamically adjusted on the premise that the individual difference dynamically changes.

Description

Technical Field

[0001] The present application relates to the field of red light emission technology, and more specifically, to a red light emission method and device capable of lowering blood sugar. Background Art

[0002] Red light emission is an important optoelectronic technology that involves light sources, equipment and applications that emit red light wavelengths. This technology has been widely used and developed in many fields. It refers to the technology of using specific materials or devices to generate red light wavelengths under the action of electric current or other energy input. Its principle is based on the electron transition process of semiconductor materials (such as gallium nitride, indium phosphide, etc.) under electric field excitation, emitting red light with a wavelength in the range of 630 nanometers to 750 nanometers. The development of this technology has promoted the realization of a variety of applications, including display technology, lighting applications, medical equipment, communications and sensors.

[0003] The application of red light emission in lowering blood sugar is an emerging and highly-watched technology. This technology uses red light of a specific wavelength to irradiate the body, thereby stimulating energy production in the mitochondria of the target object, increasing glucose consumption, and thus lowering blood sugar levels. With the further maturity of this technology and the deepening of clinical practice, red light emission technology is expected to become an important auxiliary means of diabetes management, providing more personalized and effective options for diabetic patients. However, in the existing process of lowering blood sugar by red light emission, the emission wavelength with the highest degree of blood sugar reduction is often selected as the emission wavelength of the red light emitting device. This method will cause the irradiated object to have a stress response (the stress response is manifested as abnormal increase in blood sugar) under the irradiation of the emission wavelength with the highest degree of blood sugar reduction due to individual differences in the objects irradiated by the red light emitting device (for example: different skin colors lead to different degrees of red light absorption and different body sensitivities to red light). Therefore, due to the changes in individual differences, the intensity and frequency of the stress response are different, which makes the blood sugar-lowering effect of the red light emitting device during the irradiation process uncontrollable. Therefore, how to dynamically adjust the wavelength of the red light emitting device under the premise of dynamic changes in individual differences has become a difficult problem faced by the industry. Summary of the invention

[0004] The present application provides a red light emitting method and device capable of lowering blood sugar, which can dynamically adjust the wavelength of the red light emitting device under the premise of dynamic changes in individual differences.

[0005] In a first aspect, the present application provides a red light emission method capable of lowering blood sugar, comprising the following steps:

[0006] Starting the red light emitting device, obtaining the blood sugar change record of the target object before and after being irradiated by the red light emitting device, obtaining historical blood sugar data, and then extracting abnormal blood sugar data and normal blood sugar data from the historical blood sugar data;

[0007] Determine the blood sugar change amount corresponding to each emission wavelength based on each emission wavelength in the red light emitting device and the blood sugar routine data;

[0008] Selecting an emission wavelength as the selected emission wavelength, determining a plurality of abnormal blood sugar margins according to the abnormal blood sugar record corresponding to the selected emission wavelength in the abnormal blood sugar data, and then determining the abnormal reaction entropy of blood sugar after being irradiated by the selected emission wavelength according to each abnormal blood sugar margin and the blood sugar change amount corresponding to the selected emission wavelength, and continuing to determine the abnormal reaction entropy of blood sugar after being irradiated by the remaining emission wavelengths;

[0009] Acquire light intensity reflection data of the red light emitting device, and determine the emission wavelength compensation amount of the red light emitting device according to the energy-blood sugar correlation characteristic of the red light emitting device and the light intensity reflection data;

[0010] The wavelength adjustment cost of each emission wavelength is determined by all abnormal reaction entropies and the emission wavelength compensation amount, and the wavelength of the red light emitting device is controlled according to all wavelength adjustment costs.

[0011] In some embodiments, extracting abnormal blood sugar data and normal blood sugar data from the historical blood sugar data specifically includes:

[0012] selecting a historical blood glucose group from the historical blood glucose data as a selected historical blood glucose group;

[0013] When the blood glucose value before red light irradiation in the selected historical blood glucose group is less than or equal to the blood glucose value after red light irradiation, the selected historical blood glucose group is used as the abnormal blood glucose group;

[0014] When the blood glucose value before red light irradiation in the selected historical blood glucose group is greater than the blood glucose value after red light irradiation, the selected historical blood glucose group is used as the normal blood glucose group;

[0015] Continue to judge the remaining historical blood sugar groups in the historical blood sugar data to obtain all abnormal blood sugar groups and all normal blood sugar groups;

[0016] The set of all abnormal blood sugar groups sorted in the order of sampling time is taken as abnormal blood sugar data;

[0017] The set of all blood sugar routine groups sorted in the order of sampling time is taken as blood sugar routine data.

[0018] In some embodiments, determining the blood sugar change amount corresponding to each emission wavelength based on each emission wavelength in the red light emitting device and the blood sugar routine data specifically includes:

[0019] Acquire all emission wavelengths of the red light emitting device;

[0020] Extracting the blood sugar routine records of each emission wavelength from the blood sugar routine data;

[0021] The blood sugar changes corresponding to each emission wavelength are determined through each blood sugar routine record.

[0022] In some embodiments, determining a plurality of abnormal blood sugar margins by selecting the abnormal blood sugar records corresponding to the emission wavelengths in the abnormal blood sugar data specifically includes:

[0023] Acquire the abnormal blood sugar record corresponding to the selected emission wavelength in the abnormal blood sugar data;

[0024] Get the normal range of blood sugar;

[0025] selecting a blood sugar abnormality group in the blood sugar abnormality record as a selected blood sugar abnormality group;

[0026] determining a blood sugar abnormality deviation according to the selected blood sugar abnormality group and the blood sugar normal range;

[0027] Determine the abnormal blood sugar margin corresponding to the selected abnormal blood sugar group according to the emission interval of the red light emission device and the abnormal blood sugar deviation;

[0028] Continue to determine the abnormal blood sugar margins corresponding to the remaining abnormal blood sugar groups in the abnormal blood sugar record, thereby obtaining a plurality of abnormal blood sugar margins.

[0029] In some embodiments, determining the abnormal reaction entropy of blood glucose after being irradiated by the selected emission wavelength according to each abnormal blood glucose margin and the blood glucose change amount corresponding to the selected emission wavelength specifically includes:

[0030] Determine the blood sugar reduction trend of the selected emission wavelength according to the blood sugar reduction amount corresponding to the selected emission wavelength;

[0031] The abnormal reaction entropy of blood glucose after irradiation with the selected emission wavelength is determined based on the respective blood glucose abnormal margins and the blood glucose lowering trend of the selected emission wavelength.

[0032] In some embodiments, determining the emission wavelength compensation amount of the red light emitting device according to the energy-blood sugar correlation characteristic of the red light emitting device and the light intensity reflection data specifically includes:

[0033] Obtain the rated light intensity of the red light emitting device;

[0034] Determine the light intensity absorption value at each sampling moment after the red light emitting device irradiates according to the rated light intensity and the light intensity reflection value at each sampling moment in the light intensity reflection data;

[0035] Obtaining an energy-blood sugar control ratio, wherein the energy-blood sugar control ratio is an energy-blood sugar correlation feature of a specified red light;

[0036] The emission wavelength compensation amount of the red light emitting device is determined according to the light intensity absorption values ​​corresponding to all sampling moments and the energy-blood sugar control ratio.

[0037] In some embodiments, determining the wavelength adjustment cost of each emission wavelength by using all abnormal reaction entropies and the emission wavelength compensation amount specifically includes:

[0038] Compensating each emission wavelength by the emission wavelength compensation amount to obtain a plurality of compensation wavelength amounts;

[0039] Determine the abnormal reaction ratio corresponding to each emission wavelength according to each compensation wavelength amount and all abnormal reaction entropies;

[0040] The wavelength adjustment cost of each emission wavelength is determined based on all abnormal response ratios.

[0041] In a second aspect, the present application provides a red light emitting device capable of lowering blood sugar, comprising a control unit, wherein the control unit comprises:

[0042] An acquisition module, used to acquire the blood sugar change record of the target object before and after being irradiated by the red light emitting device after the red light emitting device is started, obtain historical blood sugar data, and then extract abnormal blood sugar data and normal blood sugar data from the historical blood sugar data;

[0043] A processing module, used for determining the blood sugar change amount corresponding to each emission wavelength based on each emission wavelength in the red light emitting device and the blood sugar routine data;

[0044] The processing module is further used to select an emission wavelength as the selected emission wavelength, determine multiple blood sugar abnormality margins through the blood sugar abnormality records corresponding to the selected emission wavelength in the blood sugar abnormality data, and then determine the abnormal reaction entropy of blood sugar after being irradiated with the selected emission wavelength according to each blood sugar abnormality margin and the blood sugar change amount corresponding to the selected emission wavelength, and continue to determine the abnormal reaction entropy of blood sugar after being irradiated with the remaining emission wavelengths;

[0045] The processing module is further used to obtain light intensity reflection data of the red light emitting device, and determine the emission wavelength compensation amount of the red light emitting device according to the energy-blood sugar correlation characteristics of the red light emitting device and the light intensity reflection data;

[0046] The execution module is used to determine the wavelength adjustment cost of each emission wavelength through all abnormal reaction entropies and the emission wavelength compensation amount, and perform wavelength control on the red light emitting device according to all wavelength adjustment costs.

[0047] In a third aspect, the present application provides a computer device, including a memory and a processor, wherein the memory stores a computer program, and the processor implements the steps of the above-mentioned red light emission method when executing the computer program.

[0048] In a fourth aspect, the present application provides a computer-readable storage medium storing a computer program, which implements the steps of the above-mentioned red light emission method when executed by a processor.

[0049] The technical solution provided by the embodiments disclosed in this application has the following beneficial effects:

[0050] In the red light emission method and device capable of lowering blood sugar provided by the present application, after starting the red light emission device, the blood sugar change record of the target object before and after being irradiated by the red light emission device is obtained to obtain historical blood sugar data, and then the abnormal blood sugar data and the normal blood sugar data are extracted from the historical blood sugar data; the blood sugar change amount corresponding to each emission wavelength is determined based on each emission wavelength in the red light emission device and the normal blood sugar data; an emission wavelength is selected as the selected emission wavelength, and a plurality of abnormal blood sugar margins are determined by the abnormal blood sugar record corresponding to the selected emission wavelength in the abnormal blood sugar data, and then the abnormal reaction entropy of blood sugar after being irradiated by the selected emission wavelength is determined according to each abnormal blood sugar margin and the blood sugar change amount corresponding to the selected emission wavelength, and the abnormal reaction entropy of blood sugar after being irradiated by the remaining emission wavelengths is continued to be determined; the light intensity reflection data of the red light emission device is obtained, and the emission wavelength compensation amount of the red light emission device is determined according to the energy-blood sugar correlation characteristics of the red light emission device and the light intensity reflection data; the wavelength adjustment cost of each emission wavelength is determined according to all abnormal reaction entropies and the emission wavelength compensation amount, and the wavelength of the red light emission device is controlled according to all wavelength adjustment costs.

[0051] It can be seen that in the present application, after obtaining the blood sugar change record of the target object before and after the specified red light irradiation, the data of the stress response (i.e., abnormal blood sugar data) and the data of normal blood sugar reduction (i.e., regular blood sugar data) are extracted, and then the emission wavelengths of all red light emitting devices that are effective in lowering blood sugar are obtained, and the blood sugar lowering effect of each wavelength pair is determined, that is, the blood sugar reduction amount of each emission wavelength, and then the degree to which the blood sugar level is affected by the red light at different emission wavelengths within the time interval of red light emission is determined, that is, multiple blood sugar abnormality margins, and the sensitivity when irradiated with different emission wavelengths and the volatility of blood sugar reduction at different wavelengths are analyzed to obtain the abnormal reaction entropy of different emission wavelengths, and then the emission wavelength compensation amount of the red light emitting device is determined based on the collected light intensity reflection data, and finally, the abnormal reaction entropy affected by each emission wavelength is determined by all the abnormal reaction entropies and the emission wavelength compensation amount. During long irradiation, the blood sugar lowering effect of different emission wavelengths, that is, the wavelength adjustment cost, so that the wavelength of the red light emitting device is adjusted by all wavelength adjustment costs. This application analyzes the sensitivity of different emission wavelengths when stress response occurs and the volatility of blood sugar lowering when no stress response occurs at different wavelengths, and finds the emission wavelength with the lowest uncertainty and variability in the blood sugar lowering effect, thereby reducing the frequency of stress response caused by individual differences, and after collecting the light intensity reflection data of the red light emitting device, the proportion of energy lost due to red light reflection is used to determine the emission wavelength compensation amount of the emitted red light, thereby avoiding the reduction of the blood sugar lowering effect due to different red light absorption degrees of skin color (individual differences), and irradiating by using the emission wavelength with the highest matching degree; in summary, this scheme can dynamically adjust the wavelength of the red light emitting device under the premise of dynamic changes in individual differences. BRIEF DESCRIPTION OF THE DRAWINGS

[0052] Figure 1 It is a flow chart of a red light emission method capable of lowering blood sugar according to some embodiments of the present application;

[0053] Figure 2 It is a schematic diagram of a process of extracting routine blood sugar records according to some embodiments of the present application;

[0054] Figure 3 is a schematic diagram of a process for determining an emission wavelength compensation amount according to some embodiments of the present application;

[0055] Figure 4 is a structural block diagram of a control unit according to some embodiments of the present application;

[0056] Figure 5 It is a diagram of the internal structure of a computer device for implementing a red light emission method capable of lowering blood sugar according to some embodiments of the present application. DETAILED DESCRIPTION

[0057] The core of the present application is to obtain the blood sugar change record of the target object before and after being irradiated by the red light emitting device after starting the red light emitting device, obtain historical blood sugar data, and then extract abnormal blood sugar data and normal blood sugar data from the historical blood sugar data; determine the blood sugar change amount corresponding to each emission wavelength based on each emission wavelength in the red light emitting device and the normal blood sugar data; select an emission wavelength as the selected emission wavelength, determine multiple abnormal blood sugar margins by the abnormal blood sugar record corresponding to the selected emission wavelength in the abnormal blood sugar data, and then determine the abnormal reaction entropy of blood sugar after being irradiated by the selected emission wavelength according to each abnormal blood sugar margin and the blood sugar change amount corresponding to the selected emission wavelength, and continue to determine the abnormal reaction entropy of blood sugar after being irradiated by the remaining emission wavelengths; obtain the light intensity reflection data of the red light emitting device, and determine the emission wavelength compensation amount of the red light emitting device according to the energy-blood sugar correlation characteristics of the red light emitting device and the light intensity reflection data; determine the wavelength adjustment cost of each emission wavelength through all abnormal reaction entropies and the emission wavelength compensation amount, and perform wavelength control on the red light emitting device according to all wavelength adjustment costs; the wavelength of the red light emitting device can be dynamically adjusted under the premise of dynamic changes in individual differences.

[0058] In order to better understand the above technical solution, the above technical solution will be described in detail below in conjunction with the accompanying drawings and specific implementation methods. Figure 1 , which is a flow chart of a red light emitting method capable of lowering blood sugar according to some embodiments of the present application. The red light emitting method capable of lowering blood sugar 100 mainly comprises the following steps:

[0059] In step 101, a red light emitting device is started to obtain a record of blood sugar changes of a target object before and after being irradiated by the red light emitting device to obtain historical blood sugar data, and then abnormal blood sugar data and normal blood sugar data are extracted from the historical blood sugar data.

[0060] In specific implementation, after starting the red light emitting device, the target object's blood sugar change record before and after the specified red light irradiation can be obtained through the target object's blood sugar record log to obtain historical blood sugar data. It should be noted that the blood sugar record log includes the blood sugar value before and after the red light irradiation in each red light treatment cycle. In addition, the historical blood sugar group is represented by X i =(x ia , x ib ), where X i represents the i-th historical blood glucose group in the historical blood glucose data, x ia represents the blood glucose value before red light irradiation in the i-th historical blood glucose group, x ib It represents the blood glucose value after red light irradiation in the i-th historical blood glucose group, wherein, in the historical blood glucose data, each historical blood glucose group has a unique corresponding sampling time.

[0061] In some embodiments, the abnormal blood sugar data and normal blood sugar data can be extracted from the historical blood sugar data by the following steps:

[0062] selecting a historical blood glucose group from the historical blood glucose data as a selected historical blood glucose group;

[0063] When the blood glucose value before red light irradiation in the selected historical blood glucose group is less than or equal to the blood glucose value after red light irradiation, the selected historical blood glucose group is used as the abnormal blood glucose group;

[0064] When the blood glucose value before red light irradiation in the selected historical blood glucose group is greater than the blood glucose value after red light irradiation, the selected historical blood glucose group is used as the normal blood glucose group;

[0065] Continue to judge the remaining historical blood sugar groups in the historical blood sugar data to obtain all abnormal blood sugar groups and all normal blood sugar groups;

[0066] The set of all abnormal blood sugar groups sorted in the order of sampling time is taken as abnormal blood sugar data;

[0067] The set of all blood sugar routine groups sorted in the order of sampling time is taken as blood sugar routine data.

[0068] In step 102, the blood sugar variation corresponding to each emission wavelength is determined based on each emission wavelength in the red light emitting device and the blood sugar routine data.

[0069] It should be noted that each historical blood glucose group in the historical blood glucose data has a unique corresponding emission wavelength, and therefore, each blood glucose routine group in the blood glucose routine data has a unique corresponding emission wavelength; in some embodiments, the blood glucose change amount corresponding to each emission wavelength is determined based on each emission wavelength in the red light emitting device and the blood glucose routine data, which can be achieved by the following steps:

[0070] Acquire all emission wavelengths of the red light emitting device;

[0071] Extracting the blood sugar routine records of each emission wavelength from the blood sugar routine data;

[0072] The blood sugar changes corresponding to each emission wavelength are determined through each blood sugar routine record.

[0073] It should be noted that the present application increases the production of adenosine triphosphate in mitochondria after irradiating the target object with red light having a wavelength between 650 nanometers and 750 nanometers, thereby achieving the effect of lowering blood sugar. Therefore, as a preferred embodiment, obtaining all emission wavelengths of the red light emitting device can be achieved in the following manner, namely: taking [650, 750] as the range of the specified red light emission wavelength, and 10 nanometers as the minimum unit, thereby obtaining all emission wavelengths of the red light emitting device. In other embodiments, it can also be determined by other methods, which are not limited here.

[0074] Wherein, in some embodiments, reference Figure 2 As shown, this figure is a schematic diagram of the process of extracting blood sugar routine records shown in some embodiments of the present application. Extracting blood sugar routine records of each emission wavelength from the blood sugar routine data can be achieved by using the following steps:

[0075] First, in step 1021, an emission wavelength is selected as a selected emission wavelength;

[0076] Next, in step 1022, a blood glucose routine group of a selected emission wavelength in the blood glucose routine data is obtained;

[0077] Then, in step 1023, a set consisting of all blood sugar routine groups is used as a blood sugar routine record of the selected emission wavelength;

[0078] Finally, in step 1024, the blood glucose routine record for the remaining emission wavelengths continues to be determined.

[0079] In some embodiments, determining the blood sugar change corresponding to each emission wavelength through each blood sugar routine record can be achieved by the following steps:

[0080] selecting an emission wavelength as a selected emission wavelength;

[0081] Obtain routine blood sugar records corresponding to the selected emission wavelength;

[0082] Selecting a blood sugar routine group in the blood sugar routine record as a selected blood sugar routine group;

[0083] Determining the blood sugar impact component of the selected emission wavelength in the selected blood sugar routine group according to the selected blood sugar routine group;

[0084] Continue to use the remaining blood sugar routine groups in the blood sugar routine record as selected blood sugar routine groups in sequence, so as to determine all blood sugar influencing components of the selected emission wavelength;

[0085] Determine the blood sugar change amount corresponding to the selected emission wavelength according to all blood sugar impact components of the selected emission wavelength;

[0086] Continue to determine the blood sugar changes corresponding to the remaining emission wavelengths.

[0087] In specific implementation, determining the blood glucose impact component of the selected emission wavelength in the selected blood glucose routine group according to the selected blood glucose routine group can be achieved in the following manner, namely: first, obtaining the blood glucose value before red light irradiation and the blood glucose value after red light irradiation in the selected blood glucose routine group, and then taking the difference between the blood glucose value before red light irradiation and the blood glucose value after red light irradiation as the blood glucose impact component of the selected emission wavelength in the selected blood glucose routine group. In other embodiments, it can also be determined by other methods, which will not be repeated here.

[0088] It should be noted that the blood sugar impact component represents the degree of influence of the red light irradiation process in the selected blood sugar routine group on the blood sugar lowering effect of the selected wavelength. The larger the blood sugar impact component, the higher the degree of influence of the red light irradiation process in the selected blood sugar routine group on the blood sugar lowering effect of the selected wavelength. The smaller the blood sugar impact component, the lower the degree of influence of the red light irradiation process in the selected blood sugar routine group on the blood sugar lowering effect of the selected wavelength.

[0089] In specific implementation, determining the blood sugar change corresponding to the selected emission wavelength based on all blood sugar influencing components of the selected emission wavelength can be achieved in the following manner, namely: taking the average value of all blood sugar influencing components of the selected emission wavelength as the blood sugar change corresponding to the selected emission wavelength. In other embodiments, it can also be determined by other methods, which are not limited here.

[0090] It should be noted that the blood sugar change represents the blood sugar lowering effect of the selected emission wavelength on the target object. The higher the blood sugar change, the better the blood sugar lowering effect of the selected emission wavelength on the target object. The lower the blood sugar change, the worse the blood sugar lowering effect of the selected emission wavelength on the target object.

[0091] In step 103, an emission wavelength is selected as the selected emission wavelength, and a plurality of abnormal blood glucose margins are determined by the abnormal blood glucose records corresponding to the selected emission wavelength in the abnormal blood glucose data, and then the abnormal reaction entropy of blood glucose after irradiation with the selected emission wavelength is determined according to each abnormal blood glucose margin and the blood glucose change amount corresponding to the selected emission wavelength, and the abnormal reaction entropy of blood glucose after irradiation with the remaining emission wavelengths is continued to be determined.

[0092] It should be noted that in the present application, one emission wavelength corresponds to multiple abnormal blood sugar records. Therefore, in some embodiments, determining multiple abnormal blood sugar margins by selecting the abnormal blood sugar records corresponding to the emission wavelength in the abnormal blood sugar data can be implemented by the following steps:

[0093] Acquire the abnormal blood sugar record corresponding to the selected emission wavelength in the abnormal blood sugar data;

[0094] Get the normal range of blood sugar;

[0095] selecting a blood sugar abnormality group in the blood sugar abnormality record as a selected blood sugar abnormality group;

[0096] determining a blood sugar abnormality deviation according to the selected blood sugar abnormality group and the blood sugar normal range;

[0097] Determine the abnormal blood sugar margin corresponding to the selected abnormal blood sugar group according to the emission interval of the red light emission device and the abnormal blood sugar deviation;

[0098] Continue to determine the abnormal blood sugar margins corresponding to the remaining abnormal blood sugar groups in the abnormal blood sugar record, thereby obtaining a plurality of abnormal blood sugar margins.

[0099] In specific implementation, obtaining the normal range of blood glucose can be achieved in the following manner, namely: first, obtaining all historical blood glucose values ​​of the target object before red light irradiation in the blood glucose record log, then determining the mean and standard deviation of all historical blood glucose values ​​before red light irradiation, sampling the normal distribution in the prior art to determine the normal model of the historical blood glucose values, and then determining the historical blood glucose values ​​corresponding to the 5% distribution interval and the historical blood glucose values ​​corresponding to the 95% distribution interval in the normal model, finally, the range of historical blood glucose values ​​consisting of the historical blood glucose values ​​corresponding to the 5% distribution interval and the historical blood glucose values ​​corresponding to the 95% distribution interval is used as the normal range of blood glucose in this application.

[0100] In specific implementation, determining the abnormal blood sugar deviation according to the selected abnormal blood sugar group and the normal blood sugar range can be achieved in the following manner, namely: first, obtaining the blood sugar value after red light irradiation in the selected abnormal blood sugar group, and taking the deviation between the blood sugar value after red light irradiation and the normal blood sugar range as the abnormal blood sugar deviation of the selected abnormal blood sugar group. For example, if the blood sugar value after red light irradiation in the selected abnormal blood sugar group is 180, and the normal blood sugar range is [120, 150], then the abnormal blood sugar deviation of the selected abnormal blood sugar group is the difference between 180 and 150, that is, 30. In other embodiments, it can also be determined by other methods, which will not be repeated here.

[0101] It should be noted that in the present application, each abnormal blood sugar margin corresponds to a stress response, and the stress response refers to the different reactions to red light irradiation due to the different physiological states and metabolic characteristics of the target objects. For example, the volatility of the target object's ability to absorb red light leads to different insulin responses, thereby affecting the selected corresponding abnormal blood sugar increase. The abnormal blood sugar deviation characterizes the degree of deviation between the target object's blood sugar value after red light irradiation and the target object's blood sugar range. The larger the abnormal blood sugar deviation, the higher the degree of deviation between the target object's blood sugar value after red light irradiation and the target object's blood sugar range. The smaller the abnormal blood sugar deviation, the lower the degree of deviation between the target object's blood sugar value after red light irradiation and the target object's blood sugar range.

[0102] In specific implementation, determining the abnormal blood sugar margin corresponding to the selected abnormal blood sugar group based on the emission interval of the red light emitting device and the abnormal blood sugar deviation can be achieved in the following manner, namely: first, obtaining the time interval cost, then determining the quotient of the time interval cost and the emission interval, and finally, adding 1 to the obtained result and multiplying the result by the abnormal blood sugar deviation as the abnormal blood sugar margin corresponding to the selected abnormal blood sugar group.

[0103] It should be noted that the time interval cost is the influence of the emission interval of the red light emitting device on the blood sugar lowering effect. The larger the time interval cost, the greater the influence of the emission interval of the red light emitting device on the blood sugar lowering effect. The larger the time interval cost, the smaller the influence of the emission interval of the red light emitting device on the blood sugar lowering effect. In some preferred embodiments, the influence of the emission interval of the red light emitting device on the blood sugar lowering effect can be obtained by conducting red light irradiation experiments on the target object at different time intervals, and then the quantified value of the obtained influence effect is used as the time interval cost. In other embodiments, it can also be determined by other methods, which will not be repeated here. In addition, the abnormal blood sugar margin characterizes the degree to which the blood sugar level of the target object is affected by red light within the emission interval. The larger the abnormal blood sugar margin, the higher the degree to which the blood sugar level of the target object is affected by red light within the emission interval. The smaller the abnormal blood sugar margin, the lower the degree to which the blood sugar level of the target object is affected by red light within the emission interval.

[0104] In some embodiments, determining the abnormal reaction entropy of blood glucose after being irradiated with the selected emission wavelength according to each abnormal blood glucose margin and the blood glucose change amount corresponding to the selected emission wavelength can be achieved by the following steps:

[0105] Determine the blood sugar reduction trend of the selected emission wavelength according to the blood sugar reduction amount corresponding to the selected emission wavelength;

[0106] The abnormal reaction entropy of blood glucose after irradiation with the selected emission wavelength is determined based on the respective blood glucose abnormal margins and the blood glucose lowering trend of the selected emission wavelength.

[0107] In specific implementation, determining the blood sugar lowering trend of the selected emission wavelength based on the blood sugar lowering amount corresponding to the selected emission wavelength can be achieved in the following manner, namely: first, obtaining all blood sugar influencing components corresponding to the selected emission wavelength, secondly, selecting a blood sugar influencing component as the selected blood sugar influencing component, and then determining the square of the difference between the selected blood sugar influencing component and the blood sugar lowering amount of the selected emission wavelength, repeating the above steps, and taking the remaining blood sugar influencing components of the selected emission wavelength in turn as the selected blood sugar influencing components, thereby obtaining the results corresponding to all blood sugar influencing components of the selected emission wavelength, and finally, taking the square root of the sum of the results corresponding to all blood sugar influencing components of the selected emission wavelength as the blood sugar lowering trend of the selected emission wavelength.

[0108] It should be noted that the blood sugar lowering trend represents the volatility of the blood sugar lowering of the target object after red light irradiation. The greater the blood sugar lowering trend, the higher the volatility of the blood sugar lowering of the target object after red light irradiation. The smaller the blood sugar lowering trend, the lower the volatility of the blood sugar lowering of the target object after red light irradiation.

[0109] In specific implementation, the abnormal reaction entropy of blood glucose after irradiation with the selected emission wavelength can be determined according to each blood glucose abnormal margin and the blood glucose lowering trend of the selected emission wavelength. This can be achieved in the following manner, namely: first, the standard deviation of all abnormal margins is determined, and then the result is added to the blood glucose lowering trend of the selected emission wavelength and the result is divided by 2 as the abnormal reaction entropy of blood glucose after irradiation with the selected emission wavelength. In other embodiments, it can also be determined by other methods, which will not be repeated here.

[0110] It should be noted that the present application obtains the abnormal reaction entropy of the target object's blood sugar after being irradiated with different emission wavelengths by analyzing the sensitivity of the target object when it has a stress response to different emission wavelengths and the volatility of the target object's blood sugar reduction when it has no stress response to different wavelengths. The abnormal reaction entropy reflects the uncertainty and variability of the target object's blood sugar reduction due to different wavelengths. The larger the abnormal reaction entropy, the higher the uncertainty and variability of the corresponding wavelength for the target object's blood sugar reduction. The smaller the abnormal reaction entropy, the lower the uncertainty and variability of the corresponding wavelength for the target object's blood sugar reduction.

[0111] In step 104, light intensity reflection data of the red light emitting device is obtained, and the emission wavelength compensation amount of the red light emitting device is determined according to the energy-blood sugar correlation characteristic of the red light emitting device and the light intensity reflection data.

[0112] In specific implementation, the light intensity reflection data of the red light emitting device can be collected through an optical sensor with a predetermined sampling period, wherein it should be noted that the optical sensor described in the present application is a photodiode, and the photodiode obtains the light intensity reflection data of the red light emitting device by converting the light signal reflected by the skin surface into an electrical signal. In addition, the predetermined sampling period is 5 seconds.

[0113] In some embodiments, reference Figure 3 As shown, this figure is a schematic diagram of the process of determining the emission wavelength compensation amount shown in some embodiments of the present application. The emission wavelength compensation amount of the red light emitting device can be determined based on the energy-blood sugar correlation characteristics of the red light emitting device and the light intensity reflection data. The following steps can be used to achieve:

[0114] First, in 1041, the rated light intensity of the red light emitting device is obtained;

[0115] Next, in 1042, the light intensity absorption value at each sampling moment after the red light emitting device irradiates is determined according to the rated light intensity and the light intensity reflection value at each sampling moment in the light intensity reflection data;

[0116] Then, in 1043, an energy-blood sugar control ratio is obtained, where the energy-blood sugar control ratio is an energy-blood sugar correlation feature of the specified red light;

[0117] Finally, in 1044, the emission wavelength compensation amount of the red light emitting device is determined according to the light intensity absorption values ​​corresponding to all sampling moments and the energy-blood sugar control ratio.

[0118] It should be noted that the rated light intensity of the red light emitting device can be obtained through the factory settings of the red light emitting device, and can also be obtained through other methods in other embodiments, which are not limited here.

[0119] In specific implementation, the light intensity absorption value at each sampling moment after the red light emitting device is irradiated can be determined based on the rated light intensity and the light intensity reflection value at each sampling moment in the light intensity reflection data. This can be achieved in the following manner, namely: first, the light intensity reflection value at a sampling moment in the light intensity reflection data is selected; secondly, the difference between the rated light intensity and the light intensity reflection value is used as the light intensity absorption value at the sampling moment; the above steps are repeated to determine the light intensity absorption values ​​at the remaining sampling moments in the light intensity reflection data, thereby obtaining the light intensity absorption value at each sampling moment after the red light emitting device is irradiated. In other embodiments, the light intensity absorption value can also be determined by other methods, which are not limited here.

[0120] It should be noted that when the target object is irradiated with red light, a part of the red light intensity will be absorbed due to the skin color of the target object, that is, energy is lost, thereby reducing the blood sugar lowering effect. The present application sets a linear relationship between the wavelength compensation amount and the light intensity absorption value, and then experimentally sets the energy loss situation on the skin surface of the target object between different light intensities and different emission wavelengths. The linear relationship between the wavelength compensation amount and the light intensity absorption value is estimated by the least squares method in the prior art, thereby obtaining the energy-blood sugar control ratio. The energy-blood sugar control ratio characterizes the proportion of energy lost due to red light reflection after the specified red light passes through the skin surface of the target object at a specific wavelength. The larger the energy-blood sugar control ratio, the more energy is lost under the same light intensity, and the smaller the energy-blood sugar control ratio, the less energy is lost under the same light intensity.

[0121] In specific implementation, the emission wavelength compensation amount of the red light emitting device can be determined based on the light intensity absorption values ​​corresponding to all sampling moments and the energy-blood sugar control ratio in the following manner, namely: first, the light intensity absorption values ​​corresponding to all sampling moments are multiplied by the energy-blood sugar control ratio respectively, and the expectation of the corresponding results of all light intensity absorption values ​​is used as the emission wavelength compensation amount of the red light emitting device. In other embodiments, it can also be determined by other methods, which are not limited here.

[0122] In step 105, the wavelength adjustment cost of each emission wavelength is determined by all abnormal reaction entropies and the emission wavelength compensation amount, and the wavelength of the red light emitting device is controlled according to all wavelength adjustment costs.

[0123] In some embodiments, determining the wavelength adjustment cost of each emission wavelength by using all abnormal reaction entropies and the emission wavelength compensation amount can be implemented by the following steps:

[0124] Compensating each emission wavelength by the emission wavelength compensation amount to obtain a plurality of compensation wavelength amounts;

[0125] Determine the abnormal reaction ratio corresponding to each emission wavelength according to each compensation wavelength amount and all abnormal reaction entropies;

[0126] The wavelength adjustment cost of each emission wavelength is determined based on all abnormal response ratios.

[0127] In specific implementation, each emission wavelength is compensated by the emission wavelength compensation amount, and multiple compensation wavelength amounts can be obtained in the following manner, namely: the result of adding each emission wavelength to the emission wavelength compensation amount is used as the compensation wavelength amount corresponding to each emission wavelength. In other embodiments, it can also be determined by other methods, which are not limited here.

[0128] It should be noted that a compensation wavelength amount has a unique corresponding emission wavelength, and an emission wavelength has a unique corresponding abnormal reaction entropy, that is, a compensation wavelength amount has a unique corresponding abnormal reaction entropy. Therefore, in specific implementation, the abnormal reaction ratio corresponding to each emission wavelength can be determined according to each compensation wavelength amount and all abnormal reaction entropies. The following method can be used, that is, the result of comparing each compensation wavelength amount with the corresponding abnormal reaction entropy is used as the abnormal reaction ratio corresponding to the emission wavelength.

[0129] It should be noted that the abnormal reaction ratio described in the present application is a quantified value of the probability that the target object's blood sugar level will produce a stress reaction after being irradiated with the corresponding emission wavelength. The larger the abnormal reaction ratio, the higher the probability that the target object's blood sugar level will produce a stress reaction after being irradiated with the corresponding emission wavelength. The smaller the abnormal reaction ratio, the lower the probability that the target object's blood sugar level will produce a stress reaction after being irradiated with the corresponding emission wavelength.

[0130] In specific implementation, the wavelength adjustment cost of each emission wavelength is determined based on all abnormal reaction ratios. The following method is adopted, namely: first, the maximum abnormal reaction ratio and the minimum abnormal reaction ratio among all abnormal reaction ratios are obtained; secondly, an abnormal reaction ratio is selected to determine the result of dividing the difference between the maximum abnormal reaction ratio and the abnormal reaction ratio by the difference between the maximum abnormal reaction ratio and the minimum abnormal reaction ratio; and the result obtained by subtracting 1 is used as the wavelength adjustment cost of the emission wavelength; the above steps are repeated to determine the wavelength adjustment costs of the remaining emission wavelengths, thereby obtaining the wavelength adjustment costs of each emission wavelength.

[0131] It should be noted that the wavelength adjustment cost described in the present application represents a quantitative indicator of the degree of matching between different emission wavelengths and the target object. The larger the wavelength adjustment cost, the higher the degree of matching between the corresponding wavelength and the target object. The smaller the wavelength adjustment cost, the lower the degree of matching between the corresponding wavelength and the target object.

[0132] In some embodiments, wavelength control of the red light emitting device according to all wavelength adjustment costs can be achieved by using the following steps:

[0133] According to all wavelength adjustment costs, fluctuations of each emission wavelength are judged to obtain the effective emission wavelength of the target object;

[0134] The wavelength of the red light emitting device is adjusted according to the effective emission wavelength.

[0135] In specific implementation, the fluctuation of each emission wavelength is judged according to all wavelength adjustment costs, and the effective emission wavelength of the target object can be obtained in the following way, namely: first, all wavelength adjustment costs are compared to obtain the minimum wavelength adjustment cost, and then, the emission wavelength corresponding to the minimum wavelength adjustment cost is obtained as the effective emission wavelength of the target object.

[0136] It should be noted that the wavelength of the red light emitting device is controlled according to the effective emission wavelength, that is, by selecting the emission wavelength corresponding to the minimum wavelength adjustment cost as the effective emission wavelength of the target object, and thus taking the emission wavelength with the smallest uncertainty and variability as the emission wavelength of the target object, the stability of lowering blood sugar of the target object can be improved, thereby reducing the probability of occurrence of stress response of the target object.

[0137] In addition, in another aspect of the present application, in some embodiments, the present application provides a red light emitting device capable of lowering blood sugar, the red light emitting device comprising a control unit, the control unit in the present application can be Figures 1 to 3 The wavelength is adjusted by the method shown in Figure 4 , which is a structural block diagram of a control unit according to some embodiments of the present application, the control unit 200 includes: an acquisition module 201, a processing module 202 and an execution module 203, which are described as follows:

[0138] The acquisition module 201 in the present application is mainly used to obtain the blood sugar change record of the target object before and after being irradiated by the red light emitting device after the red light emitting device is started, obtain historical blood sugar data, and then extract abnormal blood sugar data and normal blood sugar data from the historical blood sugar data. When it is specifically implemented, the abnormal blood sugar data and normal blood sugar data can be extracted in the manner of the aforementioned step 101, which will not be repeated here;

[0139] Processing module 202, in the present application, the processing module 202 is mainly used to determine the blood sugar change amount corresponding to each emission wavelength based on each emission wavelength in the red light emitting device and the blood sugar routine data. When it is specifically implemented, the blood sugar change amount corresponding to each emission wavelength can be determined by referring to the aforementioned step 102, which will not be repeated here;

[0140] In a specific implementation, the processing module 202 in the present application is also used to select an emission wavelength as the selected emission wavelength, determine multiple abnormal blood sugar margins according to the abnormal blood sugar record corresponding to the selected emission wavelength in the abnormal blood sugar data, and then determine the abnormal reaction entropy of blood sugar after being irradiated with the selected emission wavelength according to each abnormal blood sugar margin and the blood sugar change amount corresponding to the selected emission wavelength, and continue to determine the abnormal reaction entropy of blood sugar after being irradiated with the remaining emission wavelengths. In a specific implementation, the abnormal reaction entropy of blood sugar after irradiation with the emission wavelength can be determined by referring to the aforementioned step 103, which will not be repeated here;

[0141] In addition, the processing module 202 in the present application is also used to obtain the light intensity reflection data of the red light emitting device, and determine the emission wavelength compensation amount of the red light emitting device according to the energy-blood sugar correlation characteristics of the red light emitting device and the light intensity reflection data. When it is specifically implemented, the emission wavelength compensation amount of the red light emitting device can be determined by referring to the aforementioned step 104, which will not be repeated here;

[0142] Execution module 203. In the present application, execution module 203 is mainly used to determine the wavelength adjustment cost of each emission wavelength through all abnormal reaction entropies and the emission wavelength compensation amount, and to perform wavelength adjustment on the red light emitting device according to all wavelength adjustment costs. When it is specifically implemented, the wavelength adjustment of the red light emitting device can be performed with reference to the aforementioned step 105, which will not be repeated here.

[0143] In addition, the present application also provides a computer device, which includes a memory and a processor, wherein the memory stores codes, and the processor is configured to obtain the codes and execute the above-mentioned red light emission method capable of lowering blood sugar.

[0144] In some embodiments, reference Figure 5 , which is an internal structure diagram of a computer device for implementing a red light emission method capable of lowering blood sugar according to some embodiments of the present application. The red light emission method capable of lowering blood sugar in the above embodiments can be Figure 5 The computer device 300 shown in the figure is implemented, and the computer device 300 includes at least one processor 301, a communication bus 302, a memory 303 and at least one communication interface 304.

[0145] The processor 301 may be a general-purpose central processing unit (CPU), or an application-specific integrated circuit (ASIC) or one or more components for controlling the execution of the red light emission method for lowering blood sugar in the present application.

[0146] The communication bus 302 is used to transmit information between the above components.

[0147] The memory 303 may be a read-only memory (ROM) or other types of static storage devices that can store static information and instructions, a random access memory (RAM) or other types of dynamic storage devices that can store information and instructions, or an electrically erasable programmable read-only memory (EEPROM), a compact disc read-only memory (CD-ROM) or other optical disc storage, an optical disc storage (including a compressed optical disc, a laser disc, an optical disc, a digital versatile disc, a Blu-ray disc, etc.), a magnetic disk or other magnetic storage device, or any other medium that can be used to carry or store the desired program code in the form of an instruction or data structure and can be accessed by a computer, but is not limited thereto. The memory 303 may exist independently and be connected to the processor 301 via the communication bus 302. The memory 303 may also be integrated with the processor 301.

[0148] The memory 303 is used to store the program code for executing the solution of the present application, and the execution is controlled by the processor 301. The processor 301 is used to execute the program code stored in the memory 303. The program code may include one or more software modules. The red light emission method capable of lowering blood sugar in the above-mentioned embodiment can be implemented by the processor 301 and one or more software modules in the program code in the memory 303.

[0149] The communication interface 304 uses any transceiver or other device for communicating with other devices or communication networks, such as Ethernet, radio access network (RAN), wireless local area networks (WLAN), etc.

[0150] In a specific implementation, as an embodiment, a computer device may include multiple processors, each of which may be a single-CPU processor or a multi-CPU processor. The processor here may refer to one or more devices, circuits, and / or processing cores for processing data (e.g., computer program instructions).

[0151] The above-mentioned computer device may be a general-purpose computer device or a special-purpose computer device. In a specific implementation, the computer device may be a desktop computer, a portable computer, a network server, a personal digital assistant (PDA), a mobile phone, a tablet computer, a wireless terminal device, a communication device or an embedded device. The embodiment of the present application does not limit the type of computer device.

[0152] In addition, the present application also provides a computer-readable storage medium, wherein the computer-readable storage medium stores a computer program, and when the computer program is executed by a processor, the above-mentioned red light emission method is implemented.

[0153] In summary, in the red light emission method and device capable of lowering blood sugar disclosed in the embodiment of the present application, by starting the red light emission device, the blood sugar change record of the target object before and after being irradiated by the red light emission device is obtained to obtain historical blood sugar data, and then the abnormal blood sugar data and the normal blood sugar data are extracted from the historical blood sugar data; the blood sugar change amount corresponding to each emission wavelength is determined based on each emission wavelength in the red light emission device and the normal blood sugar data; an emission wavelength is selected as the selected emission wavelength, and multiple abnormal blood sugar margins are determined by the abnormal blood sugar record corresponding to the selected emission wavelength in the abnormal blood sugar data, and then the abnormal reaction entropy of blood sugar after being irradiated by the selected emission wavelength is determined according to each abnormal blood sugar margin and the blood sugar change amount corresponding to the selected emission wavelength, and the abnormal reaction entropy of blood sugar after being irradiated by the remaining emission wavelengths is continued to be determined; the light intensity reflection data of the red light emission device is obtained, and the emission wavelength compensation amount of the red light emission device is determined according to the energy-blood sugar correlation characteristics of the red light emission device and the light intensity reflection data; the wavelength adjustment cost of each emission wavelength is determined by all abnormal reaction entropies and the emission wavelength compensation amount, and the wavelength of the red light emission device is controlled according to all wavelength adjustment costs; the wavelength of the red light emission device can be dynamically adjusted under the premise of dynamic changes in individual differences.

[0154] Although the preferred embodiments of the present application have been described, those skilled in the art may make other changes and modifications to these embodiments once they have learned the basic creative concept. Therefore, the appended claims are intended to be interpreted as including the preferred embodiments and all changes and modifications falling within the scope of the present application.

[0155] Obviously, those skilled in the art may make various changes and modifications to the present application without departing from the spirit and scope of the present application. Thus, if these modifications and variations of the present application fall within the scope of the claims of the present application and their equivalents, the present application is also intended to include these modifications and variations.

Claims

1. A red light emission method capable of lowering blood sugar, characterized in that: The steps include: Starting the red light emitting device, obtaining the blood sugar change record of the target object before and after being irradiated by the red light emitting device, obtaining historical blood sugar data, and then extracting abnormal blood sugar data and normal blood sugar data from the historical blood sugar data; Determine the blood sugar change amount corresponding to each emission wavelength based on each emission wavelength in the red light emitting device and the blood sugar routine data; Selecting an emission wavelength as the selected emission wavelength, determining a plurality of abnormal blood sugar margins according to the abnormal blood sugar record corresponding to the selected emission wavelength in the abnormal blood sugar data, and then determining the abnormal reaction entropy of blood sugar after being irradiated by the selected emission wavelength according to each abnormal blood sugar margin and the blood sugar change amount corresponding to the selected emission wavelength, and continuing to determine the abnormal reaction entropy of blood sugar after being irradiated by the remaining emission wavelengths; Acquire light intensity reflection data of the red light emitting device, and determine the emission wavelength compensation amount of the red light emitting device according to the energy-blood sugar correlation characteristic of the red light emitting device and the light intensity reflection data; The wavelength adjustment cost of each emission wavelength is determined by all abnormal reaction entropies and the emission wavelength compensation amount, and the wavelength of the red light emitting device is controlled according to all wavelength adjustment costs.

2. The method according to claim 1, characterized in that Extracting abnormal blood sugar data and normal blood sugar data from the historical blood sugar data specifically includes: selecting a historical blood glucose group from the historical blood glucose data as a selected historical blood glucose group; When the blood glucose value before red light irradiation in the selected historical blood glucose group is less than or equal to the blood glucose value after red light irradiation, the selected historical blood glucose group is used as the abnormal blood glucose group; When the blood glucose value before red light irradiation in the selected historical blood glucose group is greater than the blood glucose value after red light irradiation, the selected historical blood glucose group is used as the normal blood glucose group; Continue to judge the remaining historical blood sugar groups in the historical blood sugar data to obtain all abnormal blood sugar groups and all normal blood sugar groups; The set of all abnormal blood sugar groups sorted in the order of sampling time is taken as abnormal blood sugar data; The set of all blood sugar routine groups sorted in the order of sampling time is taken as blood sugar routine data.

3. The method according to claim 1, characterized in that Determining the blood sugar change amount corresponding to each emission wavelength based on each emission wavelength in the red light emitting device and the blood sugar routine data specifically includes: Acquire all emission wavelengths of the red light emitting device; Extracting the blood sugar routine records of each emission wavelength from the blood sugar routine data; The blood sugar changes corresponding to each emission wavelength are determined through each blood sugar routine record.

4. The method according to claim 1, characterized in that Determining a plurality of abnormal blood sugar margins by selecting the abnormal blood sugar records corresponding to the emission wavelengths in the abnormal blood sugar data specifically includes: Acquire the abnormal blood sugar record corresponding to the selected emission wavelength in the abnormal blood sugar data; Get the normal range of blood sugar; selecting a blood sugar abnormality group in the blood sugar abnormality record as a selected blood sugar abnormality group; determining a blood sugar abnormality deviation according to the selected blood sugar abnormality group and the blood sugar normal range; Determine the abnormal blood sugar margin corresponding to the selected abnormal blood sugar group according to the emission interval of the red light emission device and the abnormal blood sugar deviation; Continue to determine the abnormal blood sugar margins corresponding to the remaining abnormal blood sugar groups in the abnormal blood sugar record, thereby obtaining a plurality of abnormal blood sugar margins.

5. The method according to claim 1, characterized in that Determining the abnormal reaction entropy of blood sugar after being irradiated by the selected emission wavelength according to each blood sugar abnormal margin and the blood sugar change amount corresponding to the selected emission wavelength specifically includes: Determine the blood sugar reduction trend of the selected emission wavelength according to the blood sugar reduction amount corresponding to the selected emission wavelength; The abnormal reaction entropy of blood glucose after irradiation with the selected emission wavelength is determined based on the respective blood glucose abnormal margins and the blood glucose lowering trend of the selected emission wavelength.

6. The method according to claim 1, characterized in that Determining the emission wavelength compensation amount of the red light emitting device according to the energy-blood sugar correlation characteristics of the red light emitting device and the light intensity reflection data specifically includes: Obtain the rated light intensity of the red light emitting device; Determine the light intensity absorption value at each sampling moment after the red light emitting device irradiates according to the rated light intensity and the light intensity reflection value at each sampling moment in the light intensity reflection data; Obtaining an energy-blood sugar control ratio, wherein the energy-blood sugar control ratio is an energy-blood sugar correlation feature of a specified red light; The emission wavelength compensation amount of the red light emitting device is determined according to the light intensity absorption values ​​corresponding to all sampling moments and the energy-blood sugar control ratio.

7. The method according to claim 1, characterized in that Determining the wavelength adjustment cost of each emission wavelength by all abnormal reaction entropies and the emission wavelength compensation amount specifically includes: Compensating each emission wavelength by the emission wavelength compensation amount to obtain a plurality of compensation wavelength amounts; Determine the abnormal reaction ratio corresponding to each emission wavelength according to each compensation wavelength amount and all abnormal reaction entropies; The wavelength adjustment cost of each emission wavelength is determined based on all abnormal response ratios.

8. A red light emitting device capable of lowering blood sugar, comprising a control unit, characterized in that: The control unit comprises: An acquisition module, used to acquire the blood sugar change record of the target object before and after being irradiated by the red light emitting device after the red light emitting device is started, obtain historical blood sugar data, and then extract abnormal blood sugar data and normal blood sugar data from the historical blood sugar data; A processing module, used for determining the blood sugar change amount corresponding to each emission wavelength based on each emission wavelength in the red light emitting device and the blood sugar routine data; The processing module is further used to select an emission wavelength as the selected emission wavelength, determine multiple blood sugar abnormality margins through the blood sugar abnormality records corresponding to the selected emission wavelength in the blood sugar abnormality data, and then determine the abnormal reaction entropy of blood sugar after being irradiated with the selected emission wavelength according to each blood sugar abnormality margin and the blood sugar change amount corresponding to the selected emission wavelength, and continue to determine the abnormal reaction entropy of blood sugar after being irradiated with the remaining emission wavelengths; The processing module is further used to obtain light intensity reflection data of the red light emitting device, and determine the emission wavelength compensation amount of the red light emitting device according to the energy-blood sugar correlation characteristics of the red light emitting device and the light intensity reflection data; The execution module is used to determine the wavelength adjustment cost of each emission wavelength through all abnormal reaction entropies and the emission wavelength compensation amount, and perform wavelength control on the red light emitting device according to all wavelength adjustment costs.

9. A computer device comprising a memory and a processor, wherein the memory stores a computer program, wherein: When the processor executes the computer program, the steps of the red light emission method according to any one of claims 1 to 7 are implemented.

10. A computer-readable storage medium storing a computer program, characterized in that: When the computer program is executed by a processor, the steps of the red light emission method according to any one of claims 1 to 7 are implemented.

Images